1From the dust:extracellular vesicles as regulators of development and neuroregenerationLeon G.Coleman Jr933-9342Targeting epidermal growth factor receptor signaling to facilitate cortical injury repair?Ricardo Gómez-Oliva, Pedro Nunez-Abades, Carmen Castro935-9363Beyond functional MRI signals:molecular and cellular modifiers of the functional connectome and cognitionLorenzo Pini, Alessandro Salvalaggio, Maurizio Corbetta937-9384Alpha7 nicotinic receptors as potential theranostic targets for experimental strokeMaider Garbizu, Laura Aguado, Abraham Martín939-9405Targeting autophagy by polyphenols to prevent glycative stress-toxicity in the brainAlejandro Ponce-Mora, Eloy Bejarano941-9426Neurological consequences of human calmodulin mutationsHelene H.Jensen, Anders Olsen943-9447Does photobiomodulation require glucose to work effectively?Jaimie Hoh Kam, John Mitrofanis945-9468Perspectives in human brain plasticity sparked by glioma invasion:from intraoperative (re)mappings to neural reconfigurationsSam Ng, Hugues Duffau, Guillaume Herbet947-9489Anti-aquaporin-4 antibody(AQP4-IgG)and anti-myelin oligodendrocyte glycoprotein antibody(MOG-IgG)in the cerebrospinal fluidTetsuya Akaishi, Tatsuro Misu949-95010Autophagy in neuroinflammation after traumatic brain injuryChinmoy Sarkar, Marta M.Lipinski951-95211Use of induced pluripotent stem cell-derived brain cells,organoids,assembloids,and blood-brain barrier models in understanding alcohol and anesthetic-induced brain injuries:an emerging perspectiveXiaowen Bai953-95412TDP-43 is a key molecule accelerating development of Alzheimer's disease following traumatic brain injuryChu Chen955-95613Role of lysosomal trafficking regulator in autophagic lysosome reformation in neurons:a disease perspectivePrashant Sharma, Jenny Serra-Vinardell, Wendy J.Introne, May Christine V.Malicdan957-95814Soluble alpha-synuclein post-translational modifications:unexpected regulators of pathological alpha-synuclein amplificationSimran Kapila, Yuhan Sun, Chao Peng, Shujing Zhang959-96015New insights into the effects of APP gene dose on synapse in Down syndromeXu-Qiao Chen, Xinxin Zuo961-96216Disentangling brain PrPC proteoforms and their roles in physiology and diseaseIlaria Vanni, Nonno Romolo963-96517Phosphorylation-driven aggregative proteins in neurodegenerative diseases:implications and therapeuticsAlba Espargaró, Raimon Sabate966-96818Perspectives for delivery of therapeutics by extravasation of biodegradable microspheres in the brainAnne-Eva van der Wijk, Ed VanBavel969-97019Mitochondria replacement from transplanted amniotic fluid stem cells:a promising therapy for non-neuronal defects in spinal muscular atrophyMichela Pozzobon, Camilla Bean971-97220Is GDNF to Parkinson's disease what BDNF is to Huntington's disease?Francesca R.Fusco, Emanuela Paldino973-974 